Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 19. Mai 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8917  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178332  
   
From fat to tumor: Exploring the inflammatory bridge via CRP in obesity-related bladder cancer.
Medicine (Baltimore)
Chen J, Zuo J, Zhao J, Zhu X, Li X, Zhan P, Chen P, Nie Z, Fu Y, Wang H, Fu S.
PMID: 42152373 [PubMed - indexed for MEDLINE]


The effect of povidone-iodine-enhanced rectal enema on procedure-related infectious complications before transrectal ultrasound-guided prostate biopsy: A prospective randomized study.
Medicine (Baltimore)
Do, Aydin C, Ekici M, Ça, Öztürk M, Baykam MM.
PMID: 42152336 [PubMed - indexed for MEDLINE]


Emerging Frontiers in Prostate Cancer Diagnostics: Nanolaser-Guided Nanotechnology and Computational Biology for Biomarker Surveillance.
Anticancer Agents Med Chem
Chauhan SB, Singh I, Kalra Y, Jain C.
PMID: 42152278 [PubMed - as supplied by publisher]


Role of Bladder EpiCheck(®) in Bladder cancer: from primary diagnosis to surveillance.
J Transl Med
Figueras M, Ingelmo-Torres M, Roldan FL, Gomà E, Galve P, Mercader C, Peri L, Franco A, Asiain I, Alcaraz A, Mengual L.
PMID: 42152097 [PubMed - as supplied by publisher]


[Oligometastatic hormone-sensitive prostate cancer: when can less be more?].
Urologie
Cathomas R.
PMID: 42151597 [PubMed - as supplied by publisher]


What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients' risk of hepatic and renal deterioration during chemotherapy? A qualitative study.
BMJ Open
Ercia A, Yip M, Reed C, Steventon L, Geoghegan C, Watson M, Kennelly C, Chambers P, Al Moubayed N.
PMID: 42150828 [PubMed - indexed for MEDLINE]


Primary prevention of skin cancer in patients after kidney transplantation - a literature review.
Cancer Treat Res Commun
Nowogrodzka M, D, Chamienia A, Imko-Walczuk B.
PMID: 42150391 [PubMed - as supplied by publisher]


Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors.
JCO Precis Oncol
Oller A, Kemmeren P, Perotti D, van Tinteren H, Verschuur A, Spreafico F, Brok J, Furtwängler RCJ, Chowdhury T, Al-Saadi R, Vujanic GM, Treece AL, Drost J, van Grotel M, Mullen EA, Evageliou NF, Graf N, Hong AL, Gessler M, Geller JI, van den Heuvel-Eibrink MM.
PMID: 42150146 [PubMed - indexed for MEDLINE]


[Non-muscle-invasive urothelial carcinoma of the bladder: time for a de-escalation of treatment and aftercare].
Urologie
Heidenreich A.
PMID: 42149195 [PubMed - as supplied by publisher]


Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
Clin Cancer Res
El Ahmar N, Paul MA, Simsek B, Matar S, Jegede OA, Laimon YN, Savla V, Mohanna R, de Oliveira GR, Bagheri Sheshdeh A, Denize T, West DJ, Seager MD, Sun M, Choueiri TK, Xie W, Freeman GJ, Sharpe AH, Braun DA, Haas NB, Hammers H, Bilen MA, Stein M, Sosman JA, Wu CJ, McDermott DF, Atkins MB, Signoretti S.
PMID: 42149133 [PubMed - as supplied by publisher]


Association of renal artery variations with aggressive pathological features and poor prognosis in clear-cell renal cell carcinoma: a computed tomography-based three-dimensional reconstruction study.
Quant Imaging Med Surg
Li J, Lv D, Yao X, Sun K, Guo Z, Zhou H, Wang Q, Jia M, Shuang W.
PMID: 42147872 [PubMed]


Multiparametric magnetic resonance imaging (MRI) integrating amide proton transfer-weighted (APTw) imaging, synthetic MRI, and multiplexed sensitivity encoding diffusion-weighted imaging (MUSE DWI) in the diagnosis and grading of prostate cancer.
Quant Imaging Med Surg
Zhao Z, Zhang Q, Shi J, Bao J, Hu C, Qiao X, Zhou M, Wang X.
PMID: 42147861 [PubMed]


Prediction models in prostate cancer: a systematic review and meta-analysis.
Front Oncol
Israel EN, Niels KN, Makanjuola OO, Rotimi OA, Afolabi IS.
PMID: 42147249 [PubMed]


Electrochemical Determination of the Prostate Anti-Cancer Drug Nilutamide Using Gold Nanoparticle-Polymer Based Electrode.
ACS Omega
Karaka, , Elçi A, Karabiberoglu , Dursun Z.
PMID: 42146162 [PubMed]


Metabolic crosstalk in the bladder tumor microenvironment: lactate shuttling, amino acid dependency, and immunosuppression.
Cytotechnology
Lu H, He J, Wang H, Li W, Chang P, Li W.
PMID: 42145840 [PubMed]


Germline polygenic score for prostate cancer aggressiveness.
medRxiv
Xu GJ, Karunamuni R, Dornisch AM, Brunette CA, Danowski ME, Desai H, Dochtermann D, Garraway IP, Hauger RL, Kibel AS, Lynch JA, Pyarajan S, Rose BS, Teerlink CC, Andreassen OA, Dale AM, Donovan JL, Hamdy F, Kachuri L, Lane A, Martin RM, Mills IG, Neal DE, Turner EL, Witte JS, Schleutker J, Pashayan N, Batra J, Australian Prostate Cancer BioResource (APCB), Nordestgaard BG, Hamilton RJ, Wolk A, Albanes D, Atkins J, Blot WJ, Mucci LA, Nielsen SF, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Menegaux F, Park JY, MacInnis RJ, Rosenstein BS, Lu YJ, Watya S, Vega A, NC-LA PCaP Investigators, IMPACT Study Steering Committee and Collaborators, Kogevinas M, Wiklund F, Plym A, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ost P, Razack A, Fowke JH, Gamulin M, Usmani N, Claessens F, Castelao JE, Petrovics G, Parent MÉ, Hu JJ, Zheng W, Profile Study Steering Committee, UKGPCS collaborators, Kote-Jarai Z, Eeles RA, PRACTICAL Consortium, VA Million Veteran Program, Maxwell KN, Vassy JL, Seibert TM.
PMID: 42145622 [PubMed]


Safety of carbon-ion radiotherapy for prostate cancer after rectal surgery: a single-institution retrospective study.
J Radiat Res
Yamaguchi T, Okato A, Wakatsuki M, Miura K, Makishima H, Nakajima M, Sazuka T, Sakamoto S, Ohnishi K, Ichikawa T, Ishikawa H.
PMID: 42145265 [PubMed - as supplied by publisher]


Diabetes mellitus as a potential risk factor for severe late toxicity after stereotactic body radiotherapy for prostate cancer: a large single-institution cohort study.
J Radiat Res
Sugahara D, Yamashita H, Mizumoto H, Ueno H, Kasuga Y, Hayashi T, Yasui A, Sawayanagi S, Nozawa Y, Ogita M.
PMID: 42145256 [PubMed - as supplied by publisher]


Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review.
Chin Clin Oncol
Akai T, Yamamichi G, Miyamoto H.
PMID: 42145004 [PubMed - indexed for MEDLINE]


Enhancing urothelial carcinoma diagnosis with artificial intelligence-integrated urine cytology: Biopsy-validated accuracy and efficiency gain.
Cancer Cytopathol
Lajara S, Cuda J, Geisler DL, Staniszewski C, Yang WL, Atkison K, Lin CY, Shao G, Liu TJ, Crothers B, Dhir R, Khader SN.
PMID: 42144873 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 178332    Seite 1 von 8917  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1